Observational Study
Copyright ©The Author(s) 2020.
World J Hepatol. Jun 27, 2020; 12(6): 312-322
Published online Jun 27, 2020. doi: 10.4254/wjh.v12.i6.312
Table 3 Patients’ characteristics during follow-up
Follow-up time (mo)19.7 ± 5.8(10.1–29.4)n = 24
Patients’ care
Hospitalization
In a conventional care unit
Yes18(75)n = 24
Duration (days)6.8 ± 3.1(2–14)n = 18
In an intensive care unit0(0)n = 24
Treatment
UDCA18(75)n = 24
Cholecystectomy5(36)n = 14
Outcome
Good adherence to UDCA12(67)n = 18
UDCA efficacy17(94)n = 18
Onset of action (in weeks)3.4 ± 2.5(2–12)n = 17
Pain recurrence5(28)n = 18
UDCA intolerance2(11)n = 18
Death0(0)n = 24